Skip to content

13F-HR filed by Endurant Capital Management LP

Endurant Capital Management LP filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 63 holding rows worth $379,607,000.

Accession
0001633055-22-000005
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 63 entries on the cover page, a total value of $379,607,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $379,607,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INVACARE CORP461203AJ0NOTE 5.000%11/156,727,000$50,194,000thousands by filing date
SPY78462F103SHS101,900$46,022,000thousands by filing dateput
CENTENE CORP DEL COM15135B101Stock218,235$18,373,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW61,279$16,157,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR240,271$15,940,000thousands by filing date
Bristol-Myers Squibb Company110122108COM194,684$14,218,000thousands by filing date
ORTHOFIX MED INC68752M108COM434,803$14,218,000thousands by filing date
HUMANA INC COM444859102Stock29,120$12,672,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock131,376$11,293,000thousands by filing date
SYNEOS HEALTH INC87166B102CL A123,232$9,976,000thousands by filing date
AVANTOR INC COM05352A100Stock285,901$9,669,000thousands by filing date
BIO RAD LABS INC090572207CL A17,151$9,660,000thousands by filing date
INVACARE CORP461203AL5NOTE 5.000%11/110,097,000$9,522,000thousands by filing date
HOLOGIC INC436440101COM123,624$9,497,000thousands by filing date
SI BONE INC825704109COM413,370$9,342,000thousands by filing date
MCKESSON CORP COM58155Q103Stock29,168$8,929,000thousands by filing date
Cigna Corporation125523100COM28,717$6,881,000thousands by filing date
ELUTIA INC05479K106CL A COM1,109,479$6,601,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock44,561$5,246,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM17,232$5,199,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock65,653$4,669,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM923,963$4,574,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR2,160,890$4,451,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM3,451,958$4,246,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH46,440$4,174,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock100,299$4,151,000thousands by filing date
ADAPTHEALTH CORP00653Q102COMMON STOCK248,314$3,980,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock165,280$3,884,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK120,834$3,604,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR52,400$3,250,000thousands by filing date
IDEXX LABS INC COM45168D104Stock5,729$3,134,000thousands by filing date
QIAGEN NVN72482123SHS NEW55,656$2,727,000thousands by filing date
PREMIER INC74051N102CL A75,632$2,692,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM296,508$2,437,000thousands by filing date
METTLER TOLEDO INTERNATIONAL COM592688105Stock1,765$2,424,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM59,732$2,316,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW18,236$2,121,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM15,342$1,945,000thousands by filing date
10X GENOMICS INC CL A COM88025U109Stock24,923$1,896,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM15,400$1,826,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM6,982$1,822,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock10,379$1,695,000thousands by filing date
AFFIMED N VN01045108COM354,492$1,549,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM83,217$1,539,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM43,250$1,498,000thousands by filing date
IMMUNIC INC4525EP101COM130,567$1,475,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR4,480$1,413,000thousands by filing date
ICU MED INC44930G107COM6,093$1,357,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM38,650$1,220,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM105,792$1,219,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH126,000$1,132,000thousands by filing datecall
DAVITA INC COM23918K108Stock10,000$1,131,000thousands by filing dateput
MOLECULAR TEMPLATES INC608550109COM314,238$1,084,000thousands by filing date
CAREDX INC14167L103COM28,048$1,037,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM60,720$1,011,000thousands by filing date
NATERA INC COM632307104Stock24,747$1,007,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM59,474$988,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM3,308$939,000thousands by filing date
PRAXIS PRECISION MEDICINES I74006W108COM79,452$811,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock68,710$596,000thousands by filing date
DARIOHEALTH CORP23725P209COM73,779$431,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM243,795$322,000thousands by filing date
BIODESIX INC09075X108COM130,753$221,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001633055-22-000005this filing2022-05-16acceptance time not in the bulk data set